Reasons for success and lessons learnt from nanoscale vaccines against COVID-19
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reasons for success and lessons learnt from nanoscale vaccines against COVID-19
Authors
Keywords
-
Journal
Nature Nanotechnology
Volume 16, Issue 8, Pages 843-850
Publisher
Springer Science and Business Media LLC
Online
2021-08-12
DOI
10.1038/s41565-021-00946-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- China COVID vaccine reports mixed results — what does that mean for the pandemic?
- (2021) Smriti Mallapaty NATURE
- Looking beyond COVID-19 vaccine phase 3 trials
- (2021) Jerome H. Kim et al. NATURE MEDICINE
- Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine
- (2021) Jerald Sadoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
- (2021) Merryn Voysey et al. LANCET
- Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia
- (2021) Denis Y Logunov et al. LANCET
- J&J’s single-dose COVID vaccine raises hopes for faster rollout
- (2021) Heidi Ledford NATURE
- Covid-19: Novavax vaccine efficacy is 86% against UK variant and 60% against South African variant
- (2021) Elisabeth Mahase BMJ-British Medical Journal
- SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates
- (2021) Nikolaos C. Kyriakidis et al. npj Vaccines
- Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
- (2021) Kate-Lynn Muir et al. NEW ENGLAND JOURNAL OF MEDICINE
- Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
- (2021) Nina H. Schultz et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel coronavirus outbreak of global health concern
- (2020) Chen Wang et al. LANCET
- Nanoscale nights of COVID-19
- (2020) Kostas Kostarelos Nature Nanotechnology
- Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Feng-Cai Zhu et al. LANCET
- Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults
- (2020) Mark J. Mulligan et al. NATURE
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
- (2020) Lisa A. Jackson et al. NEW ENGLAND JOURNAL OF MEDICINE
- SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates
- (2020) Gregory A Poland et al. LANCET
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
- (2020) Edward E. Walsh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
- (2020) Cheryl Keech et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
- (2020) Lindsey R. Baden et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
- (2020) Fernando P. Polack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial
- (2020) Andrew J Pollard et al. LANCET INFECTIOUS DISEASES
- The beginning of the end of the nanomedicine hype
- (2019) Kinam Park JOURNAL OF CONTROLLED RELEASE
- Nanomedicine: From where are we coming and where are we going?
- (2019) Patrick Couvreur JOURNAL OF CONTROLLED RELEASE
- The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
- (2019) Akin Akinc et al. Nature Nanotechnology
- mRNA vaccines — a new era in vaccinology
- (2018) Norbert Pardi et al. NATURE REVIEWS DRUG DISCOVERY
- Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
- (2018) Jayesh A. Kulkarni et al. Nucleic Acid Therapeutics
- Adenovirus: The First Effective In Vivo Gene Delivery Vector
- (2014) Ronald G. Crystal HUMAN GENE THERAPY
- Influence of Polyethylene Glycol Lipid Desorption Rates on Pharmacokinetics and Pharmacodynamics of siRNA Lipid Nanoparticles
- (2013) Barbara L Mui et al. Molecular Therapy-Nucleic Acids
- The effect of artificial lipid envelopment of Adenovirus 5 (Ad5) on liver de-targeting and hepatotoxicity
- (2012) Açelya Yilmazer et al. BIOMATERIALS
- A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity
- (2012) Matthew D. J. Dicks et al. PLoS One
- Intracellular trafficking and gene expression of pH-sensitive, artificially enveloped adenoviruses in vitro and in vivo
- (2011) Jeroen Van den Bossche et al. BIOMATERIALS
- The effect of surface modification of adenovirus with an arginine-grafted bioreducible polymer on transduction efficiency and immunogenicity in cancer gene therapy
- (2009) Pyung-Hwan Kim et al. BIOMATERIALS
- Designer adenoviruses for nanomedicine and nanodiagnostics
- (2009) Ravi Singh et al. TRENDS IN BIOTECHNOLOGY
- Artificial envelopment of nonenveloped viruses: enhancing adenovirus tumor targeting in vivo
- (2008) Ravi Singh et al. FASEB JOURNAL
- Modification of Adenovirus Gene Transfer Vectors With Synthetic Polymers: A Scientific Review and Technical Guide
- (2007) Florian Kreppel et al. MOLECULAR THERAPY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started